Login to Your Account



Abundant Research, Limited Capital

Biotech Pipelines Sitting 'Unexploited' In Australia

By Jennifer Boggs


Thursday, March 23, 2006

No Abstract

 

Staff Writer

Though it represents the most prolific biotech industry in the Asia-Pacific region, Australia is a land of untapped early stage drug discoveries.

A haven for research and innovation led by more than 400 biotech firms, many of them spun out of local universities and research institutes, the country down under has faced challenges in attracting venture capital funding.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription